Novartis producing from Holly Springs vax plant; India's PM wants to do more for pharma; SAFC pairs with Baxter on ADCs;

> Novartis ($NVS) is now manufacturing the new cell-based vaccine from its plant in Holly Springs. Story

> Indian Prime Minister Narendra Modi wants to draw more investment in pharma, as well as other kinds of manufacturing. Story

> Sigma-Aldrich Corporation's SAFC and Baxter's ($BAX) BioPharma Solutions group have struck a deal to offer clients a service where SAFC will do conjugation and manufacture drug linkers for antibody-drug conjugate products and BioPharma will do the sterile fill/finish work. Release

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.